TY - JOUR
T1 - Harmonization of growth hormone measurement results
T2 - the empirical approach
AU - Ross, H.A.
AU - Lentjes, E.G.W.M.
AU - Menheere, P.M.M.
AU - Sweep, C.G.J.
N1 - Copyright © 2014 Elsevier B.V. All rights reserved.
PY - 2014/5/15
Y1 - 2014/5/15
N2 - Growth hormone (hGH) is a measurand belonging to ISO category 4, indicating intrinsic unavailability of a reference measurement procedure and primary standard material. Large between-method differences have been raising confusion, especially in the interpretation of results of stimulation tests for exclusion of juvenile growth hormone deficiency. Within the framework of the external quality assessment scheme (EQAS) of the SKML (Dutch Foundation for Quality Assessment in Clinical Laboratories), attempts to reduce between-method variation of hGH measurements have been made, starting in 1994 with an inter-laboratory comparison of 9 different immunoassays by using a panel of sera and standard materials available at that time. Methods appeared to differ from each other largely in a systematic, sample-independent manner. These systematic differences are reflected in the hGH measurement results obtained in commutable sera. A commutable serum pool was introduced as a consensus reference material, permitting correction of each method's results to a common scale. Pair wise comparisons ("twin studies") were carried out to investigate and corroborate the effectiveness of this material for harmonization. A significant reduction of the between-laboratory coefficient (CV) of variation from 22 to 9.0% was attained.
AB - Growth hormone (hGH) is a measurand belonging to ISO category 4, indicating intrinsic unavailability of a reference measurement procedure and primary standard material. Large between-method differences have been raising confusion, especially in the interpretation of results of stimulation tests for exclusion of juvenile growth hormone deficiency. Within the framework of the external quality assessment scheme (EQAS) of the SKML (Dutch Foundation for Quality Assessment in Clinical Laboratories), attempts to reduce between-method variation of hGH measurements have been made, starting in 1994 with an inter-laboratory comparison of 9 different immunoassays by using a panel of sera and standard materials available at that time. Methods appeared to differ from each other largely in a systematic, sample-independent manner. These systematic differences are reflected in the hGH measurement results obtained in commutable sera. A commutable serum pool was introduced as a consensus reference material, permitting correction of each method's results to a common scale. Pair wise comparisons ("twin studies") were carried out to investigate and corroborate the effectiveness of this material for harmonization. A significant reduction of the between-laboratory coefficient (CV) of variation from 22 to 9.0% was attained.
KW - Blood Chemical Analysis/standards
KW - Human Growth Hormone/blood
KW - Humans
KW - Reference Standards
KW - Regression Analysis
U2 - 10.1016/j.cca.2014.01.008
DO - 10.1016/j.cca.2014.01.008
M3 - Article
C2 - 24508625
SN - 0009-8981
VL - 432
SP - 72
EP - 76
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
ER -